5-Year Follow-up of Children and Mother After Expectant Management Versus Induction of Labor in Low-risk Nulliparous Women at 39 Weeks of Gestation

by palligoelme@gmail.com | Jan 9, 2026 | Clinical Trials

​ Conditions: Neurodevelopmental Disorders Interventions: Behavioral: Questionnaires Sponsors: University Hospital, Bordeaux; French Ministry of Social Affairs and Health Not yet recruiting Conditions: Neurodevelopmental Disorders Interventions: Behavioral:...

ALSS – DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF

by palligoelme@gmail.com | Jan 9, 2026 | Clinical Trials

​ Conditions: Acute Liver Failure Interventions: Device: The artificial liver support system (ALSS) – DPMAS/TPE Sponsors: Institute for Clinical and Experimental Medicine Recruiting Conditions: Acute Liver Failure Interventions: Device: The artificial liver...

Neurobiological and Genomic Predictors of Relapse in Depression

by palligoelme@gmail.com | Jan 9, 2026 | Clinical Trials

​ Conditions: Healthy; Major Depressive Disorder (MDD) Interventions: Drug: Antidepressant Medications Sponsors: Mehmet Kemal Arikan Recruiting Conditions: Healthy; Major Depressive Disorder (MDD) Interventions: Drug: Antidepressant Medications Sponsors: Mehmet Kemal...

Effect of Exercises on Ventilatory Function in Adult With TOF

by palligoelme@gmail.com | Jan 8, 2026 | Clinical Trials

​ Conditions: Tetralogy of Fallot (TOF); Adults With Repaired Tetralogy of Fallot Interventions: Other: aerobic exercise; Other: respiratory muscle training Sponsors: Cairo University Not yet recruiting Conditions: Tetralogy of Fallot (TOF); Adults With Repaired...

Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

by palligoelme@gmail.com | Jan 8, 2026 | Clinical Trials

​ Conditions: Ischemic Stroke, Acute Interventions: Drug: non-immunogenic staphylokinase; Drug: Placebo Sponsors: Supergene, LLC Not yet recruiting Conditions: Ischemic Stroke, Acute Interventions: Drug: non-immunogenic staphylokinase; Drug: Placebo Sponsors:...